as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹656.1
Change
+20.75 (3.27%)
Open
₹630.35
Prev. Close
₹635.35
Day High
₹660.0
Day Low
₹630.35
Volume Analysis
Traded
372,268
Delivered
158,466
Delivery %
42.57%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Low return on equity (9.52%)
- •Promoter holding is falling
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹696.94 | ₹678.47 | ₹667.29 | ₹648.82 | ₹637.64 | ₹619.17 | ₹607.99 |
| Fibonacci | ₹678.47 | ₹667.14 | ₹660.15 | ₹648.82 | ₹637.49 | ₹630.5 | ₹619.17 |
| Camarilla | ₹664.25 | ₹661.54 | ₹658.82 | ₹648.82 | ₹653.38 | ₹650.66 | ₹647.95 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-7.2%
1 Week
+4.6%
1 Month
-4.01%
3 Months
+7.88%
6 Months
+14.5%
1 Year
+0.94%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹277.41
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
9.3%
Net margin 6.64% × asset turnover 0.8x × equity multiplier 1.75x
Company Overview
Sector
Chemicals
Market Cap
₹10,448 Cr
P/E (TTM)
32.9
ROE
9.52%
Book Value
₹196.0
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.
TopFund Analysis
Jubilant Ingrevia Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 62/100. The strongest factor is Financial Strength (100/100), while Valuation (43/100) is the weakest area to weigh before deciding. Notably: Low return on equity (9.52%); promoter holding is falling.
TopFund Score — Fundamentals Quality
62/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has been maintaining a healthy dividend payout of 34.4%
- +Company's working capital requirements have reduced from 29.4 days to 22.0 days
- −Stock is trading at 3.34 times its book value
- −Company has a low return on equity of 8.49% over last 3 years.
- −Company might be capitalizing the interest cost
- −Promoter holding has decreased over last 3 years: -6.25%
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Record date set for ₹100 crore commercial paper maturity on December 22, 2026.
Issued Rs. 100 crore commercial papers for 90 days at 6.30%, maturing December 23, 2026.
7th AGM held August 26, 2026; all resolutions passed, including Rs.2.50 final dividend.
Jubilant Ingrevia to acquire 40% stake in Zettaone for ₹189.2 crore; closes by November 2026 and September 2027.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,075 | 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 |
| Expenses + | 958 | 902 | 871 | 983 | 915 | 921 | 918 | 905 | 896 | 985 | 924 | 1,016 | 1,101 |
| Operating Profit | 117 | 118 | 96 | 91 | 110 | 124 | 138 | 147 | 142 | 135 | 126 | 163 | 199 |
| OPM % | 11.0% | 12.0% | 10.0% | 8.0% | 11.0% | 12.0% | 13.0% | 14.0% | 14.0% | 12.0% | 12.0% | 14.0% | 15.0% |
| Other Income + | 8 | 9 | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 | -4 | 9 | 10 |
| Interest | 11 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 | 12 | 12 | 17 |
| Depreciation | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 | 45 | 48 | 51 |
| Profit before tax | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 | 65 | 112 | 141 |
| Tax % | 29.0% | 28.0% | 30.0% | 43.0% | 26.0% | 26.0% | 27.0% | 27.0% | 25.0% | 25.0% | 28.0% | 23.0% | 25.0% |
| Net Profit + | 58 | 57 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 |
| EPS in Rs | 4 | 4 | 2 | 2 | 3 | 4 | 4 | 5 | 5 | 4 | 3 | 5 | 7 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 0 | 684 | 4,949 | 4,773 | 4,136 | 4,178 | 4,388 | 4,651 |
| Expenses + | 0 | 567 | 4,108 | 4,224 | 3,708 | 3,658 | 3,820 | 4,027 |
| Operating Profit | 0 | 117 | 841 | 549 | 427 | 519 | 568 | 624 |
| OPM % | — | 17.0% | 17.0% | 11.0% | 10.0% | 12.0% | 13.0% | 13.0% |
| Other Income + | 0 | -10 | 22 | 32 | 29 | 38 | 27 | 27 |
| Interest | 0 | 7 | 31 | 22 | 53 | 56 | 49 | 54 |
| Depreciation | 0 | 22 | 123 | 122 | 136 | 158 | 175 | 186 |
| Profit before tax | 0 | 77 | 709 | 437 | 268 | 344 | 370 | 411 |
| Tax % | 0.0% | 30.0% | 33.0% | 30.0% | 32.0% | 27.0% | 25.0% | — |
| Net Profit + | 0 | 54 | 477 | 308 | 183 | 251 | 278 | 309 |
| EPS in Rs | -3 | 3 | 30 | 19 | 11 | 16 | 17 | 19 |
| Dividend Payout % | 0.0% | 10.0% | 17.0% | 26.0% | 43.0% | 31.0% | 28.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Reserves | 0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 | 3,110 |
| Borrowings + | 0 | 556 | 238 | 407 | 740 | 764 | 792 |
| Other Liabilities + | 0 | 888 | 1,111 | 1,176 | 1,241 | 1,324 | 1,551 |
| Total Liabilities | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,470 |
| Fixed Assets + | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,581 | 3,183 |
| CWIP | 0 | 65 | 174 | 525 | 331 | 525 | 154 |
| Investments | 0 | 50 | 6 | 8 | 15 | 37 | 33 |
| Other Assets + | 0 | 1,446 | 1,804 | 1,870 | 1,834 | 1,872 | 2,099 |
| Total Assets | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,470 |
| Equity Capital | 0 | 16 | 16 | 16 | 16 | 16 | 16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 0 | 112 | 453 | 462 | 430 | 508 | 524 |
| Cash from Investing Activity + | 0 | 33 | -71 | -469 | -568 | -389 | -250 |
| Cash from Financing Activity + | 0 | -72 | -418 | 42 | 144 | -129 | -155 |
| Net Cash Flow | 0 | 73 | -36 | 35 | 6 | -9 | 119 |
| CFO/OP | 0 | 106 | 69 | 98 | 111 | 113 | 111 |
| Free Cash Flow | 0 | 85 | 225 | -16 | -136 | 156 | 235 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Others | 0.82% | 0.82% | 0.81% | 0.81% | 0.77% | 0.74% | 0.73% | 0.72% | 0.82% | 0.8% | 0.98% | 0.98% |
| Public | 32.22% | 30.17% | 27.53% | 27.1% | 25.09% | 24.9% | 24.76% | 25.3% | 24.94% | 23.8% | 22.53% | 22.3% |
| Promoters | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% | 45.22% | 45.22% | 45.22% | 45.22% | 45.22% |
| Government | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.02% | 0.02% | 0.02% | 0.02% |
| FII | 6.3% | 6.35% | 6.58% | 6.55% | 7.22% | 6.89% | 7.12% | 6.96% | 5.96% | 6.15% | 6.49% | 6.49% |
| DII | 9.18% | 11.17% | 13.6% | 14.07% | 15.47% | 15.99% | 15.91% | 21.81% | 23.04% | 24.0% | 24.76% | 24.98% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Jubilant Ingrevia Limited (this stock) | 10,448 | 32.9 | 3.35 | 9.52% |
| Sudarshan Chemical Inds L | 9,704 | 95.6 | 2.78 | 0.54% |
| Alkyl Amines Chem. Ltd | 9,526 | 50.2 | 17.73 | 41.4% |
| Swan Corp Limited | 9,242 | 41.3 | 1.23 | -4.5% |
| Guj Nar Val Fer & Chem L | 9,159 | 8.81 | 1.0 | 9.14% |
| Clean Science & Tech Ltd | 8,896 | 38.2 | 5.62 | 15.3% |
| Vinati Organics Ltd | 12,506 | 27.9 | 3.95 | 14.9% |
Which Mutual Funds Hold Jubilant Ingrevia Limited?
Frequently Asked Questions about Jubilant Ingrevia Limited
Jubilant Ingrevia Limited (JUBLINGREA) closed at ₹656.1 on NSE on 25 September 2026, up 20.75 (3.27%) from the previous close.
Jubilant Ingrevia Limited trades on the NSE (National Stock Exchange of India) under the symbol JUBLINGREA.
Jubilant Ingrevia Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 32.9.
Jubilant Ingrevia Limited has a dividend yield of 0.76%.
Jubilant Ingrevia Limited's 52-week high is ₹795.0 and its 52-week low is ₹535.0.
Jubilant Ingrevia Limited has a market capitalisation of ₹10,448 crore.
Jubilant Ingrevia Limited has a TopFund Quality Score of 62/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Jubilant Ingrevia Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.